China Tian Yuan Healthcare : Further Delay in Dispatch of Circular in relation to Major Transaction in respect of Extension of the New Facility

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA TIAN YUAN HEALTHCARE GROUP LIMITED

中國天元醫療集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 557)

FURTHER DELAY IN DISPATCH OF CIRCULAR

IN RELATION TO MAJOR TRANSACTION IN RESPECT OF

EXTENSION OF THE NEW FACILITY

References are made to the announcement of the Company dated 12 November 2019 in relation to the major transaction in respect of extension of the new facility (the "Announcement") and announcements of the Company dated 3 December 2019 and 6 January 2020 in relation to the delay in dispatch of the Circular (the "Delay in Dispatch Announcements"). Unless otherwise stated, capitalised terms used herein shall have the same meanings as those defined in the Announcement and the Delay in Dispatch Announcements.

As disclosed in the Delay in Dispatch Announcements, the expected dispatch date of the Circular was postponed to a date falling on or before 3 February 2020. Since additional time is required to prepare and finalise certain information to be included in the Circular, it is expected that the dispatch date of the Circular will be further postponed to a date falling on or before 28 February 2020.

By order of the Board

China Tian Yuan Healthcare Group Limited

Jiang Yulin

Chairman

Hong Kong, 3 February 2020

As at the date of this announcement, the Board is composed of eight directors of which Mr. Jiang Yulin (chairman) and Ms. Zhang Xian are the executive directors, Ms. He Mei, Mr. Zhang Yupeng and Mr. Zhou Yuan are the non-executive directors and Mr. Hu Baihe, Mr. Yuen Kwok Kuen and Mr. Guo Jingbin are the independent non-executive directors.